DXR Stock - Daxor Corp.

DXR Stock Chart

DXR Profile

Daxor Corporation operates as a medical device company specializing in blood volume measurement technology. The company focuses on developing and marketing the BVA-100 Blood Volume Analyzer, a diagnostic tool designed to provide precise and objective quantification of blood volume status and composition. This technology compares patient-specific measurements against established norms, facilitating its application across a wide spectrum of medical and surgical conditions.

Formerly known as Idant Corporation, Daxor Corporation underwent a name change in May 1973. Established in 1971 and headquartered in Oak Ridge, Tennessee, the company has established itself as a leader in blood volume testing technology. The BVA-100 Blood Volume Analyzer is utilized by healthcare professionals to enhance clinical decision-making, particularly in critical care settings where accurate blood volume assessment is crucial for optimal patient management.

Daxor Corporation continues to innovate in the field of medical diagnostics, leveraging its expertise to provide healthcare providers with advanced tools for assessing blood volume dynamics. With a commitment to improving patient outcomes through precision medicine, the company remains dedicated to expanding its technology's applications and advancing medical understanding of blood volume-related conditions.

DXR Revenue Chart

DXR Earnings

Analyst Ratings